Active dendritic cell immunotherapy for glioblastoma: Current status and challenges-Reference-Cited by-同舟云学术

Active dendritic cell immunotherapy for glioblastoma: Current status and challenges

Published:2014-12-26 Issue:2 Volume:29 Page:197-205
ISSN:0268-8697
Container-title:British Journal of Neurosurgery
language:en
Short-container-title:British Journal of Neurosurgery

Author:

Polyzoidis Stavros,Tuazon Juel,Brazil Lucy,Beaney Ronald,Al-Sarraj Safa Taha,Doey Lawrence,Logan Jamie,Hurwitz Victoria,Jarosz Jozef,Bhangoo Ranjeev,Gullan Richard,Mijovic Aleksandar,Richardson Mark,Farzaneh Farzin,Ashkan Keyoumars

Publisher

Informa UK Limited

Subject

Clinical Neurology,General Medicine,Surgery

Link

http://www.tandfonline.com/doi/pdf/10.3109/02688697.2014.994473

Reference41 articles.

1. Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. Perry J, Okamoto M, Guiou M,et al. Novel Therapies in Glioblastoma.Neurol Res International2012; Article ID 428565, 14 pages.

4. The art of gene therapy for glioma: a review of the challenging road to the bedside

5. Sipuleucel-T

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface engineered nanodiamonds: mechanistic intervention in biomedical applications for diagnosis and treatment of cancer;Biomedical Materials;2024-04-15

2. A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges;Frontiers in Pharmacology;2023-04-19

3. Cell Therapy: Types, Regulation, and Clinical Benefits;Frontiers in Medicine;2021-11-22

4. Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge;Frontiers in Immunology;2021-09-16

5. Nanopolymeric systems to improve brain cancer treatment outcomes;Advances and Challenges in Pharmaceutical Technology;2021